Overview
Angel Robles-Marhuenda practices in La Paz, Spain. Robles-Marhuenda is rated as an Experienced expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). Their top areas of expertise are Chronic Granulomatous Disease, Common Variable Immune Deficiency, Multicentric Castleman Disease (MCD), and Lymphofollicular Hyperplasia.
Their clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Multicentric Castleman Disease (MCD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Granulomatous DiseaseRobles-Marhuenda isAdvanced. Learn about Chronic Granulomatous Disease.
- Common Variable Immune DeficiencyRobles-Marhuenda isAdvanced. Learn about Common Variable Immune Deficiency.
- Experienced
- Adult Still's DiseaseRobles-Marhuenda isExperienced. Learn about Adult Still's Disease.
- Antiphospholipid SyndromeRobles-Marhuenda isExperienced. Learn about Antiphospholipid Syndrome.
- ArthritisRobles-Marhuenda isExperienced. Learn about Arthritis.
- CardiomyopathyRobles-Marhuenda isExperienced. Learn about Cardiomyopathy.
- Castleman DiseaseRobles-Marhuenda isExperienced. Learn about Castleman Disease.
- Congenital Heart BlockRobles-Marhuenda isExperienced. Learn about Congenital Heart Block.